Beta Bionics, Inc. Common Stock (BBNX) is a publicly traded Healthcare sector company. As of May 21, 2026, BBNX trades at $10.11 with a market cap of $418.88M and a P/E ratio of 0.00. BBNX moved +7.43% today. Year to date, BBNX is -65.81%; over the trailing twelve months it is -36.17%. Its 52-week range spans $8.80 to $32.71. Analyst consensus is strong buy with an average price target of $19.00. Rallies surfaces BBNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BBNX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $10.11 |
| Market Cap | $418.88M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.71 |
| 52-Week Low | $8.80 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover BBNX: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.00.